NPI: 1942406756 · NEW YORK, NY 10013 · 207W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,851 | $217K |
| 2019 | 4,135 | $265K |
| 2020 | 2,940 | $208K |
| 2021 | 3,905 | $240K |
| 2022 | 4,057 | $257K |
| 2023 | 4,223 | $322K |
| 2024 | 3,608 | $242K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | 4,042 | 4,033 | $473K | |
| 92134 | 8,617 | 8,564 | $306K | |
| 99213 | 3,168 | 3,079 | $226K | |
| 67028 | 2,383 | 2,251 | $166K | |
| 99204 | 1,061 | 1,056 | $157K | |
| J0178 | Aflibercept injection | 200 | 189 | $148K |
| 92201 | 3,496 | 3,441 | $76K | |
| J9035 | Bevacizumab injection | 1,193 | 1,146 | $68K |
| 67145 | 204 | 187 | $63K | |
| 92225 | 1,196 | 760 | $32K | |
| 92226 | 978 | 597 | $24K | |
| 92235 | 83 | 77 | $8K | |
| 92250 | 79 | 78 | $3K | |
| J0179 | Inj, brolucizumab-dbll, 1 mg | 19 | 19 | $79.63 |